Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.160.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BE.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.177.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CA.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BF.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CA.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BM.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.2.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.177.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.2.4 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.161SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.75SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.411SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.217SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.17 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.527SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.500SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.147SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.487SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.121SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AS.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.115SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BM.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
DE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
BF.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used